New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus¹
Go back to New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus¹| Zoetis (NYSE: ZTS) | Delayed: 81.28 +1.66 (2.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.62 | 52 Week High | $53.14 | |||
| Open | $79.90 | 52 Week Low | $38.26 | |||
| Day High | $82.08 | P/E | 80.48 | |||
| Day Low | $79.90 | EPS | $1.01 | |||
| Volume | 1,355,545 | |||||



